HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Betaine Mitigates Amyloid-β-Associated Neuroinflammation by Suppressing the NLRP3 and NF-κB Signaling Pathways in Microglial Cells.

AbstractBACKGROUND:
Microglia-driven neuroinflammation has been shown to be involved in the entire process of Alzheimer's disease (AD). Betaine is a natural product that exhibits anti-inflammatory activity; however, the exact underlying molecular mechanisms are poorly understood.
OBJECTIVE:
Our study focused on determining the effect of betaine against amyloid-β42 oligomer (AβO)-induced inflammation in microglial BV2 cells and investigating the underlying mechanism.
METHODS:
AβO was used to establish an in vitro AD model using BV2 cells. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide assay was used to measure BV2 cell viability with different concentrations of AβO and betaine. Reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assays were used to determine the expression levels of inflammatory factors, such as interleukin-1β (IL-1β), interleukin-18 (IL-18), and tumor necrosis factor α (TNF-α). Western blotting was used to evaluate the activation of the NOD-like receptor pyrin domain containing-3 (NLRP3) inflammasome and nuclear transcription factor-κB p65 (NF-κB p65). Moreover, we used phorbol 12-myristate 13-acetate (PMA) to activate NF-κB in order to validate that betaine exerted anti-neuroinflammatory effects through regulation of the NF-κB/NLRP3 signaling pathway.
RESULTS:
We used 2 mM betaine to treat 5μM AβO-induced microglial inflammation. The administration of betaine effectively decreased the levels of IL-1β, IL-18, and TNF-α without affecting cell viability in BV2 microglial cells.
CONCLUSION:
Betaine inhibited AβO-induced neuroinflammation in microglia by inhibiting the activation of the NLRP3 inflammasome and NF-κB, which supports further evaluation of betaine as a potential effective modulator for AD.
AuthorsYue Zhang, Jianping Jia
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 94 Issue s1 Pg. S9-S19 ( 2023) ISSN: 1875-8908 [Electronic] Netherlands
PMID37334594 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • NF-kappa B
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Inflammasomes
  • Interleukin-18
  • Betaine
  • Tumor Necrosis Factor-alpha
  • Amyloid beta-Peptides
Topics
  • Humans
  • NF-kappa B (metabolism)
  • Microglia (metabolism)
  • NLR Family, Pyrin Domain-Containing 3 Protein (metabolism)
  • Inflammasomes (metabolism)
  • Interleukin-18 (metabolism)
  • Betaine (pharmacology, metabolism)
  • Neuroinflammatory Diseases
  • Tumor Necrosis Factor-alpha (metabolism)
  • Signal Transduction
  • Inflammation (chemically induced, drug therapy, metabolism)
  • Amyloid beta-Peptides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: